Loozy vs MEDVi

MEDVi has an open FDA warning letter dated February 20, 2026. Loozy has none. No price lines up like for like. They share compounded semaglutide injection, but Loozy's $199 is a 3-month prepaid rate.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Loozy / MEDVi

Loozy logo

Loozy

6.8/10

MEDVi logo

MEDVi

7.7/10

FDA warning letters
None on record
Pharmacy
None named in our record
Lowest standing price
$199/moCompounded semaglutide injection, 3-month prepaid plan
$199/moCompounded semaglutide injection
States
All 50 states
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026

Neither Loozy nor MEDVi pays us. Links to them earn nothing. Scores: Loozy 6.8, MEDVi 7.7. How we are paid

What the record shows

  1. 01

    MEDVi has an open FDA warning letter dated February 20, 2026. Loozy has none.

  2. 02

    MEDVi names three pharmacies, all 503A. Loozy names no compounding pharmacy in our record.

  3. 03

    No price lines up like for like. They share compounded semaglutide injection, but Loozy's $199 is a 3-month prepaid rate.

  4. 04

    Loozy does not state its cancellation terms; MEDVi states you can cancel at any time.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Loozy

MEDVi

Compounded semaglutide injection

$199/mo

3-month prepaid plan; not compared

$199/mo

$2,388 a year

Price includes
Medication, clinician visits
Medication, clinician visits, shipping, coaching
Cancel any time
Not stated
Yes, stated
Minimum term
Plans are billed as 3-month plans
None; billed monthly
Refunds
Not stated
Full refund if medically disqualified, or if canceled within 72 hours before any service; none for months already billed
Early-exit fee
Not stated
None stated

Read off each seller’s own pages. Loozy: October 8, 2026. MEDVi: October 25, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Loozy

6.8/10
  • No FDA warning letter on record
  • Names no compounding pharmacy
  • Lowest price is a 3-month prepaid rate

The case for MEDVi

7.7/10
  • Names its compounding pharmacy
  • States you can cancel at any time
  • Open FDA warning letter, February 20, 2026

Scores

Loozy 6.8 · MEDVi 7.7 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
5.0

Effectiveness25%

8.5A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
6.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

5.5A
vs
B
8.5

The score is the same formula for every seller. Payment does not enter it. Method

Loozy vs MEDVi: questions

MEDVi has an open FDA warning letter dated February 20, 2026. Loozy has none. Letters are matched to a seller by company, domain and address, never by a similar name.
MEDVi names three pharmacies, all 503A. Loozy names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like. They share compounded semaglutide injection, but Loozy's $199 is a 3-month prepaid rate. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Loozy does not state its cancellation terms. MEDVi states you can cancel at any time; refunds: full refund if medically disqualified, or if canceled within 72 hours before any service; none for months already billed.
Neither Loozy nor MEDVi pays us. Links to them earn nothing. Scores: Loozy 6.8, MEDVi 7.7.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Matched on molecule, form and price. Every pair we list · The register